![Jing Marantz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Marantz
Net worth: 572 373 $ as of 30/12/2025
Profile
Dr. Jing L. Marantz is a Senior Vice President-Medical Affairs at Acceleron Pharma, Inc. She is on the Board of Directors at Krystal Biotech, Inc. Dr. Marantz was previously employed as a Head-Medical Affairs & Senior Vice President by Alnylam Pharmaceuticals, Inc., a Vice President-Medical Affairs by ARIAD Pharmaceuticals, Inc., and a Vice President-Global Medical Affairs by Alexion Pharmaceuticals, Inc. She received her MBA from Haas School of Business, a doctorate degree from Tongji Medical College of Huazhong University of Sci & Tech and a doctorate degree from Medical University of South Carolina.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/03/2025 | 12,558 ( 0.01% ) | 553 180 $ | 30/12/2025 | |
| 08/06/2025 | 3,131 ( 0.01% ) | 19 193 $ | 30/12/2025 |
Jing Marantz active positions
| Companies | Position | Start |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 06/12/2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 08/11/2022 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Former positions of Jing Marantz
| Companies | Position | End |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Director/Board Member | 17/01/2022 |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 31/10/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/05/2018 |
| ARIAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jing Marantz
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company, which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Develops technology and therapeutics for rare diseases | |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Develops technology and therapeutics for rare diseases | |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Develops pharmaceuticals |
- Stock Market
- Insiders
- Jing Marantz
